Dextromethorphan

Back to search

Molecule Structure

Scientific Name

Dextromethorphan

Description of the Drug

Dextromethorphan is an NMDA receptor antagonist used to treat cases of dry cough.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00514

Brand Name(s)

Not Available

Company Owner(s)

Lannett Co Inc, Taro Pharmaceutical Industries Ltd, Mayne Pharma Inc, Amneal Pharmaceuticals, Padagis Us Llc, Sun Pharmaceutical Industries Ltd, Avanir Pharmaceuticals Inc, Ani Pharmaceuticals Inc, Acella Pharmaceuticals Llc, Alpharma Us Pharmaceuticals Division

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Sigma opioid receptor SINGLE PROTEIN AGONIST CHEMBL287
Glutamate [NMDA] receptor subunit epsilon 1 SINGLE PROTEIN ANTAGONIST CHEMBL1972

Unichem Links

SureChEMBL SCHEMBL29949
PharmGKB PA449273
WDI DEXTROMET
DrugBank DB00514
PubChem: Thomson Pharma 15197408 14750569
PubChem 5360696
LINCS LSM-2726
BindingDB 50366613
EPA CompTox Dashboard DTXSID3022908
DrugCentral 842
Metabolights MTBLC92579 MTBLC4470
Brenda 24585
Guide to Pharmacology 6953
GSRS 18e34494-7681-4990-aa38-cf7c8d40bce1
rxnorm DEXTROMETHORPHAN DEXTROMETHORPHAN POLISTIREX DELSYM DEXTROMETHORPHAN HYDROBROMIDE
ChEBI 4470
ZINC ZINC000003201907